v3.25.2
CONDENSED STATEMENTS OF CONSOLIDATED CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   631,000,000      
Beginning balance at Dec. 31, 2023   $ 6 $ 8,604 $ 1,092 $ (35)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of Common Stock, net of issuance costs (in shares)   9,000,000      
Issuances of Common Stock, net of issuance costs   $ 0 247    
Issuances related to benefit and investment plans (in shares)   2,000,000      
Issuances related to benefit and investment plans   $ 0 (15)    
Net income $ 578     578  
Common Stock dividends declared (see Note 15)       (128)  
Other comprehensive income (loss) 5       5
Ending balance (in shares) at Jun. 30, 2024   642,000,000      
Ending balance at Jun. 30, 2024 10,354 $ 6 8,836 1,542 (30)
Beginning balance (in shares) at Mar. 31, 2024   633,000,000      
Beginning balance at Mar. 31, 2024   $ 6 8,583 1,442 (33)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of Common Stock, net of issuance costs (in shares)   9,000,000      
Issuances of Common Stock, net of issuance costs   $ 0 244    
Issuances related to benefit and investment plans (in shares)   0      
Issuances related to benefit and investment plans   $ 0 9    
Net income 228     228  
Common Stock dividends declared (see Note 15)       (128)  
Other comprehensive income (loss) 3       3
Ending balance (in shares) at Jun. 30, 2024   642,000,000      
Ending balance at Jun. 30, 2024 $ 10,354 $ 6 8,836 1,542 (30)
Beginning balance (in shares) at Dec. 31, 2024 651,727,276 652,000,000      
Beginning balance at Dec. 31, 2024 $ 10,666 $ 6 9,105 1,572 (17)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of Common Stock, net of issuance costs (in shares)   0      
Issuances of Common Stock, net of issuance costs   $ 0 0    
Issuances related to benefit and investment plans (in shares)   1,000,000      
Issuances related to benefit and investment plans   $ 0 2    
Net income 495     495  
Common Stock dividends declared (see Note 15)       (144)  
Other comprehensive income (loss) $ 0       0
Ending balance (in shares) at Jun. 30, 2025 652,814,271 653,000,000      
Ending balance at Jun. 30, 2025 $ 11,019 $ 6 9,107 1,923 (17)
Beginning balance (in shares) at Mar. 31, 2025   652,000,000      
Beginning balance at Mar. 31, 2025   $ 6 9,097 1,869 (17)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of Common Stock, net of issuance costs (in shares)   0      
Issuances of Common Stock, net of issuance costs   $ 0 0    
Issuances related to benefit and investment plans (in shares)   1,000,000      
Issuances related to benefit and investment plans   $ 0 10    
Net income 198     198  
Common Stock dividends declared (see Note 15)       (144)  
Other comprehensive income (loss) $ 0       0
Ending balance (in shares) at Jun. 30, 2025 652,814,271 653,000,000      
Ending balance at Jun. 30, 2025 $ 11,019 $ 6 $ 9,107 $ 1,923 $ (17)